Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11291693 Bacteria engineered to treat metabolic diseases

Patent 11291693 was granted and assigned to Synlogic on April, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Synlogic

Current Assignee

Synlogic

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11291693

Patent Inventor Names

Vincent M. Isabella0

Yves Millet0

Adam Fisher0

Dean Falb0

Jonathan W. Kotula0

Paul F. Miller0

Sarah Rowe0

Date of Patent

April 5, 2022

Patent Application Number

15738174

Date Filed

June 24, 2016

Patent Citations Received

‌

US Patent 11642363 Altering microbial populations and modifying microbiota

‌

US Patent 12076375 Treating and preventing

Patent Primary Examiner

CPC Code

...

Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of attenuating metabolic diseases are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11291693 Bacteria engineered to treat metabolic diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API